Divi's Laboratories Ltd.

NSE: DIVISLAB | BSE: 532488 | ISIN: INE361B01024 | Industry: Pharmaceuticals
| Expensive Performer
6756.5000 -130.50 (-1.89%)
NSE May 25, 2026 15:31 PM
Volume: 874.0K
High volume today

logo
Divi's Laboratories Ltd.
24 Jul 2017, 03:06PM
6756.50
-1.89%
buy
by HDFC Securities
HDFC Securities
Revenue decreased by 23.01% to Rs. 821.2 Cr in Q1FY18 when compared to the previous quarter. Revenue decreased by 23.01% to Rs. 821.2 Cr in Q1FY18 when compared to the previous quarter.
 
Number of FII/FPI investors decreased from 868 to 842 in Mar 2026 qtr
More from Divi's Laboratories Ltd.
Recommended
SMEs dominate primary market as new issues and listings line up
| 25 May 2026, 05:54PM
Market closes higher on US-Iran peace deal optimism
Trendlyne Marketwatch | 25 May 2026, 03:57PM
Custom synthesis business drives growth for Divi’s Laboratories
| 10 Mar 2022